Trulieve Cannabis Corp. Subordinate Voting Shares

Trulieve Cannabis Corp. Subordinate Voting Shares

10.33
USD
-0.57
(-5.23%)
-2.28EPS
1.86BMarket Cap
Mar 04Next Earn
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
- -
- -
- -
- -
0.74
2.29
4.59
6.69
6.48
5.98
6.24
6.17
5.62
Basic EPS, GAAP
-0.04
0.01
- -
- -
0.08
0.48
0.55
0.13
-1.31
-2.79
-0.82
-0.61
-2.32
Free Cash Flow per Basic Share
-0.02
-0.02
- -
- -
-0.14
-0.5
-0.37
-2.04
-0.88
0.8
0.65
1.11
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
- -
- -
- -
- -
0.79
1.28
3.79
11.89
10.38
8.83
7.51
6.86
4.53
Tangible Book Value per Share
- -
- -
- -
- -
0.72
0.96
2.44
1.45
0.83
0.08
-0.49
-0.71
0.66
Basic Weighted Avg Shares
4
4
110
110
102
110
114
139
188
189
190
191
192
Sales/Revenue/Turnover
- -
- -
- -
- -
75
253
522
932
1,218
1,129
1,186
1,181
1,081
Operating Margin (%)
-16,912.65
-23,717.76
- -
- -
34.13
44.83
41.87
22.47
10.32
8.2
7.8
12.56
12.22
Depreciation Expense
- -
- -
- -
- -
2
16
30
78
186
171
166
173
131
Net Income, GAAP
- -
- -
- -
- -
8
53
63
18
-246
-527
-155
-116
-446
Effective Tax Rate (%)
- -
- -
- -
- -
67.03
48.79
59.99
82.68
- -
- -
462.59
227.51
- -
Profit Margin (%)
-14,768.75
10,162.02
- -
- -
10.59
21
12.08
1.93
-20.2
-46.65
-13.07
-9.85
-41.22
Working Capital
- -
- -
- -
- -
34
113
185
355
383
362
466
436
461
LT Debt
- -
- -
- -
- -
10
77
266
832
943
770
797
533
555
Total Equity
- -
- -
- -
- -
76
133
448
2,147
1,928
1,409
1,249
1,143
772
Return on Invested Capital (%)
- -
- -
- -
- -
16.52
35.31
18.07
1.87
- -
- -
-16.54
-9.64
- -
Return on Capital (%)
- -
-10.71
- -
- -
18.55
37.35
14.92
1.26
- -
- -
-17.55
-10.13
- -
Return on Common Equity (%)
- -
- -
- -
- -
- -
50.74
21.69
1.39
-12.07
-31.49
-11.59
-9.61
-45.08

Capital Structure

USD

•

in mil. unless spec.
Mar'26
Jun'26
Sep'26
ST Debt
31
26
27
LT Borrowings
286
285
285
LT Finance Leases
312
266
270
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
170
192
171
Market Capitalization
948
1,891
1,859

Working Capital

USD

•

in mil. unless spec.
Mar'26
Jun'26
Sep'26
Total Current Assets
653
565
563
Cash, Cash Equivalents & STI
353
325
327
Accounts Receivable, Net
14
4
4
Inventories
242
187
191
Total Current Liabilities
124
95
102
Payables & Accruals
79
61
68
ST Debt
31
26
27
Deferred Revenue
10
7
6

Growth Rates

USD

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
-3,380.17%
64.49%
-8.49%
Free Cash Flow
8,563.84%
78.46%
71.47%
Net Income, GAAP
-2,833.73%
-303.48%
-24.97%
Sales/Revenue/Turnover
- -
21.34%
-0.45%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

USD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
298
303
284
301
1,186
2025
298
302
288
293
1,181
2026
287
271
230
- -
- -

Quarterly Earnings Per Share

USD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
-0.12
-0.06
-0.32
-0.31
-0.82
2025
-0.17
-0.07
-0.14
-0.22
-0.61
2026
0.01
-2.11
- -
- -
- -

Quarterly Dividends Per Share

USD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Company Description

CEO
Kimberly A. Rivers
Full Time Employees
5,000
Sector
Process industries
Industry
Agricultural commodities/Milling
Address
3494 Martin Hurst Road Tallahassee FL United States 32312
IPO Date
Sep 25, 2018
Business
Trulieve Cannabis Corp. engages in vertically integrated cannabis operations across the United States, focusing on cultivation, processing, distribution, and retail sales of medical and adult-use cannabis products. The company manufactures and distributes a wide range of cannabis花 products, including flower, concentrates, edibles, tinctures, topicals, and related ancillary products through company-owned dispensaries and, in some states, delivery channels, under multiple brand lines. Main products and services: - Cultivation and production: indoor and greenhouse cultivation; extraction and manufacturing of cannabis concentrates and oil-based products; cryo-freeze and other advanced processing methods; development of pre-rolls and finished consumer goods. - Retail and distribution: branded dispensaries offering direct-to-consumer sales of cannabis and derivative products; in-state medical and adult-use retail operations; managed delivery services where permitted; wholesale supply of products to partner retailers in select markets. - Product categories and brands: cannabis flower; concentrates (cannabis oils, distillates, and extracts); edibles (gummies, chocolates, baked goods); topicals (creams and balms); beverages and other derivative formats; consumer packaging and accessories; proprietary and partner brands such as Avenue, Cultivar Collection, Muse, Modern Flower, Alchemy, Momenta, Sweet Talk, Co2lors, Loveli, Trekkers, and Roll One. - Ancillary services: quality control laboratories, post-harvest processing, packaging and labeling compliance, product development and R&D for new formats and dosage forms, and compliance support for regulated markets. Latest major company changes: - Strategic expansion in key markets through acquisitions and integrations of dispensaries or cultivation facilities to broaden geographic footprint and increase retail density; these moves include consolidations and divestitures of ancillary facilities as part of portfolio optimization. - Regulatory and market expansion efforts, including pursuing state-by-state growth with enhanced vertical integration capabilities, enabling more control over supply chains and product quality. - Product and branding updates across platforms, including new product launches and expansions of existing brand lines to address evolving consumer preferences and regulatory changes. - Corporate restructurings and leadership announcements aligned with growth strategies and capital efficiency goals, including realignment of operating segments to reflect state-level operations rather than traditional multi-segment reporting. Industry context and target markets: - Industry: cannabis, with operations spanning cultivation, processing, distribution, and retail within regulated U.S. markets. - Segments: medical cannabis, adult-use recreational cannabis, and derivative product trends such as concentrates, edibles, and topicals. - Customer base: registered medical cannabis patients and adult-use consumers in states where the company operates, with a growing emphasis on brand-based consumer shopping experiences at company-owned locations and compliance-backed delivery where available. - Geographic footprint: United States, with a focus on states permitting medical and/or adult-use cannabis sales; headquarters and primary operational hubs located in states with established cultivation and retail infrastructure. Founding and corporate structure: - Founding year: established prior to the 2010s as a pioneer in vertically integrated cannabis operations in the U.S. - Headquarters: United States (headquarters locations in states where the company maintains primary corporate functions and strategic leadership). - Subsidiaries/affiliates: operates through a network of owned and operated dispensaries, cultivation facilities, processing labs, and distribution centers; maintains relationships with state regulators and license holders to support regulated commerce. Note: Trulieve emphasizes a vertically integrated, asset-light approach where feasible within state-by-state regulatory constraints, leveraging in-house cultivation, processing, and retail networks to optimize product quality, supply chain efficiency, and direct-to-consumer accessibility. The company maintains a broad portfolio of products and brands designed to address diverse consumer preferences and medical needs while pursuing ongoing expansion and regulatory advancement across the U.S. market.

Company News

  • Trulieve to Open Medical Cannabis Dispensary in Tampa, Florida

  • Trulieve to Open Medical Cannabis Dispensary in Tampa, Florida

  • Trulieve Announces Preliminary Addition to the Russell 2000® and 3000® Indices

  • Trulieve Announces November 2026 Event Participation

  • Trulieve Cannabis Q3 Earnings Call Highlights

  • Trulieve Expands Medical Cannabis Access through Riverside Pharmacy in Gainesville, Georgia

  • Trulieve Cannabis Q3 Earnings Call Highlights

  • Trulieve Cannabis Corp. (TRLV) Q3 2026 Earnings Call Transcript

  • Trulieve Reports Third Quarter 2026 Results

  • Trulieve Receives DEA Registrations for State-Licensed Medical Marijuana Operations

  • Trulieve Cannabis Corp (TRLV) Shares Fall 4.6% -- GF Value Says Still Overvalued

  • Head to Head Analysis: Sol-Gel Technologies (NASDAQ:SLGL) vs. Trulieve Cannabis (NYSE:TRLV)

  • 3 Medical Product Stocks Positioned to Ride on the Industry Tailwinds

  • Trulieve Repays $65 Million Mortgage Strengthening Balance Sheet

  • Trulieve Cannabis Corp. to Hold Third Quarter 2026 Results Conference Call on November 5, 2026

  • 2 High-Octane Cannabis Stocks to Buy in October for Aggressive Investors

  • Trulieve Cannabis (NYSE:TRLV) Shares Gap Down – Should You Sell?

  • MSOS: Pause On Cannabis Rescheduling - And Why Trulieve Is A Sneaky Pick

  • 3 Cannabis Stocks to Watch Heading Out of September

  • Trulieve Announces Exclusive Master Licensing Agreement with Connected for Florida and Texas